Replimune Group Inc Virtual Investor Event Corporate Call Transcript
Good morning, and thank you for joining our midyear data update event. And before we begin, I need to highlight our forward-looking statement on Slide 2. I'm Philip Astley-Sparke, CEO of Replimune. And I have with me today, Dr. Robert Coffin, our President and Chief R&D Officer; we also have Dr. Mark Middleton, Professor of Experimental Cancer Medicine and Consultant Medical Oncologist at the Oxford Cancer Center and the Head of the Department of Oncology at the University of Oxford.
Slide 3 shows the agenda for the call, which will start with a brief [berth] introduction from me and a brief summary of the high level updated results by Rob, followed by discussion of the results in number of the individual patients by Dr. Middleton. Rob will then provide an overview of what will be one strand of our future development efforts with RP2, 3.
Following the presentation, we'll be holding a live Q&A. To ask a question, please type your question and click submit in the Q&A section on the bottom of your
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
